Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Herrmann

Showing results (41-50 of 470) with videos related to

Pageof 47
Sort By:
CNS Drugs|August 13, 2013
Current place of monoamine oxidase inhibitors in the treatment of depressionKenneth I Shulman, Nathan Herrmann, Scott E Walker
Journal of Geriatric Psychiatry and Neurology|April 5, 2011
Validity and responsiveness to change of clinically derived MDS scales in Alzheimer disease outcomes researchKelly A Smart, Nathan Herrmann, Krista L Lanctôt
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 16, 2005
Galantamine treatment of problematic behavior in Alzheimer disease: post-hoc analysis of pooled data from three large trialsNathan Herrmann, Kiran Rabheru, Jenny Wang, et al.
International Journal of Geriatric Psychiatry|December 3, 2016
Depression with inflammation: longitudinal analysis of a proposed depressive subtype in community dwelling older adultsDamien Gallagher, Alex Kiss, Krista Lanctot, et al.
Alzheimer'S Research & Therapy|February 26, 2014
Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012Nathan Herrmann, Krista L Lanctôt, David B Hogan
International Journal of Geriatric Psychiatry|October 30, 2018
Clock drawing and neuroanatomical correlates: A systematic reviewThitiporn Supasitthumrong, Nathan Herrmann, Chavit Tunvirachaisakul, et al.
Therapeutic Advances in Neurological Disorders|December 24, 2010
Therapy for Alzheimer's Disease: How Effective are Current Treatments?Krista L Lanctôt, Ryan D Rajaram, Nathan Herrmann
International Journal of Geriatric Psychiatry|February 16, 2006
Effect of antidepressant use on admissions to hospital among elderly bipolar patientsAyal Schaffer, Muhammad Mamdani, Anthony Levitt, et al.
Journal of Clinical Psychopharmacology|June 19, 2013
Cross-national comparison of antidepressant utilization in North America and EuropeKyle J Wilby, Nathan Herrmann, Muhammad M Mamdani
Journal of Psychiatry & Neuroscience : JPN|February 18, 2003
Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's diseaseKrista L Lanctôt, Nathan Herrmann, Maysoon M LouLou
Pageof 47

Showing results (41-50 of 470) with videos related to

Sort By:
Pageof 47
CNS Drugs|August 13, 2013
Current place of monoamine oxidase inhibitors in the treatment of depressionKenneth I Shulman, Nathan Herrmann, Scott E Walker
Journal of Geriatric Psychiatry and Neurology|April 5, 2011
Validity and responsiveness to change of clinically derived MDS scales in Alzheimer disease outcomes researchKelly A Smart, Nathan Herrmann, Krista L Lanctôt
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 16, 2005
Galantamine treatment of problematic behavior in Alzheimer disease: post-hoc analysis of pooled data from three large trialsNathan Herrmann, Kiran Rabheru, Jenny Wang, et al.
International Journal of Geriatric Psychiatry|December 3, 2016
Depression with inflammation: longitudinal analysis of a proposed depressive subtype in community dwelling older adultsDamien Gallagher, Alex Kiss, Krista Lanctot, et al.
Alzheimer'S Research & Therapy|February 26, 2014
Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012Nathan Herrmann, Krista L Lanctôt, David B Hogan
International Journal of Geriatric Psychiatry|October 30, 2018
Clock drawing and neuroanatomical correlates: A systematic reviewThitiporn Supasitthumrong, Nathan Herrmann, Chavit Tunvirachaisakul, et al.
Therapeutic Advances in Neurological Disorders|December 24, 2010
Therapy for Alzheimer's Disease: How Effective are Current Treatments?Krista L Lanctôt, Ryan D Rajaram, Nathan Herrmann
International Journal of Geriatric Psychiatry|February 16, 2006
Effect of antidepressant use on admissions to hospital among elderly bipolar patientsAyal Schaffer, Muhammad Mamdani, Anthony Levitt, et al.
Journal of Clinical Psychopharmacology|June 19, 2013
Cross-national comparison of antidepressant utilization in North America and EuropeKyle J Wilby, Nathan Herrmann, Muhammad M Mamdani
Journal of Psychiatry & Neuroscience : JPN|February 18, 2003
Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's diseaseKrista L Lanctôt, Nathan Herrmann, Maysoon M LouLou
Pageof 47